American Society of Hirudotherapy

Analysis of antibiotic resistant infections associated with hirudotherapy

Research article published in American journal of otolaryngology (2024)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Safety & Infection ControlClinical TrialsBrauer P et al. · American journal of otolaryngology, 2024

Summary

Given rising concern regarding antibiotic resistance, our objective was to evaluate antibiotic-resistant infections following leech therapy and to characterize the use of prophylactic antibiotics.

Why This Matters for Hirudotherapy

Informs safety protocols and infection prevention strategies for clinical leech therapy.

Citation

Analysis of antibiotic resistant infections associated with hirudotherapy.

Brauer P et al. · American journal of otolaryngology, 2024

DOI

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.